Literature DB >> 29631247

Non-adherence to antipsychotic medication in first-episode psychosis patients.

Lauren M Hickling1, Stefanie Kouvaras2, Zaklin Nterian2, Rocio Perez-Iglesias3.   

Abstract

This study evaluated the influence of attitudes and beliefs towards antipsychotics on adherence, and aimed to understand how satisfaction with information impacts adherence in first-episode psychosis. Fifty randomly selected out-patients attending the COAST Early Intervention service completed a survey comprised of the Selwood Compliance Scale, Beliefs about Medicines Questionnaire, and the Satisfaction with Information about Medicines Scale. Thirty-four percent of patients reported non-adherence to antipsychotic medication, and they were significantly younger than adherent patients. Adherent patients were more satisfied with medication information than non-adherent patients (65.7% and 34.3% respectively), suggesting that providing better information about antipsychotics may improve adherence.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Medication adherence; Patient satisfaction; Psychotic disorders

Mesh:

Substances:

Year:  2018        PMID: 29631247     DOI: 10.1016/j.psychres.2018.04.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Parents' satisfaction with information received on psychotropic drugs used by adolescents in a Mental Health Unit.

Authors:  Dafny Oliveira de Matos; Patrícia Medeiros-Souza; Renata Passos de Melo; Ricardo Azevedo de Menezes; Noemia Urruth Leão Tavares
Journal:  Rev Paul Pediatr       Date:  2022-05-11

2.  Development and validation of the Patient's Health Belief Questionnaire on Psychiatric Treatment.

Authors:  Carlos De Las Cuevas; Jose de Leon
Journal:  Patient Prefer Adherence       Date:  2019-04-10       Impact factor: 2.711

3.  Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.

Authors:  Julien Elowe; Julie Ramain; Alessandra Solida; Philippe Conus; Philippe Golay
Journal:  Eur Psychiatry       Date:  2022-08-15       Impact factor: 7.156

Review 4.  Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.

Authors:  Edward Chesney; Dominic Oliver; Philip McGuire
Journal:  Psychopharmacology (Berl)       Date:  2021-07-13       Impact factor: 4.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.